| Item 8.01. | Other Events. |
On September 8, 2008, Salix Pharmaceuticals, Ltd. issued a press release announcing that the company has commenced patent infringement litigation against Novel Laboratories with respect to OsmoPrep. A copy of this press release is attached as Exhibit 99.1.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 | Press release dated September 8, 2008. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| SALIX PHARMACEUTICALS, LTD. | ||
| Date: September 8, 2008 | ||
| /s/ Adam C. Derbyshire | ||
| Adam C. Derbyshire | ||
| Senior Vice President and Chief Financial Officer |